This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Amtek (AME) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is Agilent (A) Up 5.3% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tencent (TCEHY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Tencent's (TCEHY) fourth-quarter results are likely to be hurt by the stalled video game approval process in China that was in place for the majority of 2018.
Booking Holdings (BKNG) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Booking Holdings' (BKNG) fourth-quarter results benefit from strong performance of its agency, merchant, advertising and other businesses.
Square (SQ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Square's (SQ) fourth-quarter results gain from acquisition contributions, growing bitcoin revenues and robust product lines.
Top Ranked Momentum Stocks to Buy for February 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 28th:
Top Ranked Momentum Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th:
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
Top Ranked Momentum Stocks to Buy for February 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 25th:
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Will New Technologies Benefit Agilent (A) in Q1 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal first-quarter 2019 results.
3 Things to Know About Q4 Earnings Season
by Sheraz Mian
We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Agilent (A) to Expand Cell Analysis Offerings in Ireland
by Zacks Equity Research
Agilent (A) is set to expand the Cork facility in Ireland in a bid to expand its capabilities in the cell analysis space.
Agilent Technologies (A) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Agilent Technologies (A) shares rose almost 8% in the last trading session, amid huge volumes.
Agilent (A) Surpasses Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Agilent (A) reports strong fiscal fourth-quarter results on broad-based growth in all its product lines.